Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 42 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Vlachaki, Efthymia [Clear All Filters]
Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis..
Clin Gastroenterol Hepatol. 13(1), 55-63.e5.
(2015). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis..
Eur J Haematol. 98(6), 563-568.
(2017). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.
European Journal of Haematology. 98111125151171328622526459851317339343312102118301141312212432349259292117201512520158233100(6), 563 - 568.
(2017). Beta-thalassemia: renal complications and mechanisms: a narrative review..
Hematology. 24(1), 426-438.
(2019). Biochemical and imaging markers in patients with thalassaemia..
Hellenic J Cardiol.
(2020). A Case of Fatal Agranulocytosis That Developed in a Patient with β-Thalassemia Major Treated with Deferiprone..
Hemoglobin. 40(6), 435-437.
(2016). Coinheritance of Triplicated Alpha-Globin Gene and Beta-Thalassemia Mutations in Adulthood: Ten Years of Referrals in Northern Greece..
J Pediatr Hematol Oncol. 42(8), e762-e764.
(2020). Compound Heterozygosity for Silent Cap +1570 (T>C) (HBB: c*96T>C), Codon 39 (C>T) (HBB: c.118C>T) and the Presence of ααα/αα in Greece. A Case Presentation..
Hemoglobin. 42(3), 194-195.
(2018). Cutaneous manifestations of mantle cell lymphoma: an extensive literature review..
Acta Dermatovenerol Alp Pannonica Adriat. 29(4), 185-191.
(2020). Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre..
Br J Haematol. 181(1), 140-142.
(2018). Evaluation of Mental Health and Physical Pain in Patients with β-Thalassemia Major in Northern Greece..
Hemoglobin. 39(3), 169-72.
(2015). Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients..
Ann Hematol. 96(11), 1937-1944.
(2017). Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
Annals of Hematology. 9635386959511886953716410511460363056271262012394215457(1111435131343Suppl 21151168618233445), 1937 - 1944.
(2017). evidence of complement activation in patients with sickle cell disease..
Haematologica. 102(12), e481-e482.
(2017). Fatal chylous ascites, pericarditis and extensive venous thrombosis, due to an aggressive T cell non-Hodgkin lymphoma..
Ann Hematol. 88(4), 371-3.
(2009). Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major..
Hemoglobin. 39(5), 299-304.
(2015). Haematoma caused by bone marrow aspiration and trephine biopsy..
Hematol Rep. 3(3), e25.
(2011). High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes..
Acta Haematol. 124(3), 141-9.
(2010). Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea..
Hum Genomics. 12(1), 45.
(2018). Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?.
Int J Hematol. 103(5), 537-44.
(2016). A man with fever and haemoglobinuria after blood transfusion..
BMJ. 362, k3138.
(2018). National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality..
Ann Hematol. 98(1), 55-66.
(2019). Necrobiosis Lipoidica in a Patient with β-Thalassemia Major: A Case Report and Review of the Literature..
Hemoglobin. 44(3), 221-223.
(2020). A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia..
N Engl J Med. 382(13), 1219-1231.
(2020).
(2017).